Sleep apnea as a risk factor for hypertension

Area of Science:

• Cardiology
• Sleep Medicine
• Hypertension Research

Background:

• Obstructive sleep apnea (OSA) is a significant risk factor for developing and worsening hypertension.
• The condition is characterized by intermittent hypoxia and sympathetic nervous system activation, leading to cardiovascular strain.
• Hypertension associated with OSA is often resistant to conventional antihypertensive therapies.

Purpose of the Study:

• To review epidemiological data on the link between preclinical OSA and hypertension.
• To explore additional contributing factors to high blood pressure in OSA patients.
• To identify optimal therapeutic strategies for managing hypertension in the context of OSA.

Main Methods:

• Review of epidemiological studies on sleep apnea and hypertension.
• Analysis of physiological mechanisms linking OSA to elevated blood pressure.
• Evaluation of treatment outcomes for OSA and associated hypertension.

Main Results:

• Cardiovascular effects of OSA, including elevated diastolic blood pressure and loss of nocturnal dipping, are evident even in early stages.
• Sympathetic activation, renin-angiotensin system, and pro-inflammatory cytokines contribute to OSA-induced hypertension.
• Treatments for OSA, such as positive airway pressure, surgery, and weight loss, effectively manage associated hypertension, while antihypertensive drugs show limited efficacy.

Conclusions:

• Early-stage OSA is associated with significant hypertension and cardiovascular risks.
• Effective hypertension management in OSA patients relies on addressing the underlying sleep disorder and obesity.
• Targeting OSA and weight is superior to solely relying on antihypertensive medications.